Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Tuberculosis (TB), a highly contagious chronic bacterial infection, is still a leading killer of young adults worldwide. TB has recently emerged as a major health concern. Each year, approximately 2 million persons worldwide die and 9 million become infected. TB has returned with a new face and the global scourge multidrug resistant TB (MDR-TB) is reaching epidemic proportions. The prevalence of TB is continuing to increase because of the increased number of patients infected with human immunodeficiency virus, bacterial resistance to medications, increased international travels and immigration from countries with high prevalence, and the growing numbers of homeless and drug abusers. TB is treated with a multidrug regimen, and is thus exceptionally vulnerable to incidences of side effects, unsatisfactory patient compliances and slow improvement of patients.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi